 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| RXMD Announces Record Breaking November Continues Year to Year Growth in Revenue and Prescriptions Filled |
|
 Hot Stock to Watch |
Company: Progressive Care Inc. (OTCQB: RXMD)
|
Last:
Price: 0.057
Change (%): - 0.003 (5)
Volume: 59,555 |
 |
Progressive Care Inc. Announces Record-Breaking November 2018
MIAMI, Dec. 12, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and a record-breaking number of prescriptions filled for November 2018.
In November, the company reported a total of $1.85 million in net revenue, a 7% increase from the same month last year, and a 40% increase in prescriptions filled during the same month last year, totaling nearly 31,500 prescriptions filled. The Company’s Miami location filled a record number of prescriptions during the month of November 2018 at over 29,000 prescriptions.
“November was a big month for us. Progressive Care broke records on prescription filling and is moving forward on major initiatives,” said S. Parikh Mars, CEO of Progressive Care. “In November, we began the process of securing ownership of our first property, issuing an LOI for our next acquisition, focusing our efforts on promotion and development of our Tele-PharmCo platform, and accelerating the growth of our core business. We are confident that our high standards for patient service and value-added healthcare management offerings will lead to continued growth for many more record-breaking months to come.”
Continue Reading
|
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
